A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab (Q33731695)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab |
scientific article |
Statements
1 reference
A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab (English)
1 reference
Primal Kaur
1 reference
Vincent Chow
1 reference
Nan Zhang
1 reference
Michael Moxness
1 reference
Arunan Kaliyaperumal
1 reference
Richard Markus
1 reference
27 July 2016
1 reference
1 reference
76
1 reference
526-533
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference